NCT00004899View on ClinicalTrials.gov

Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1999

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Interventions
BIOLOGICAL

filgrastim

DRUG

busulfan

DRUG

etoposide

PROCEDURE

autologous bone marrow transplantation

Trial Locations (1)

60611

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00004899 - Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter